Transferrin 

TRF - NOCO

In-patient: 1 mL plasma from Green top (Lithium Heparin)
Out-patient: 1 mL serum from SST

0.5 mL

1.0 mL serum from SST or Red Top

Patient should be fasting.

Temperature	Time
Ambient	5 days
Refrigerated	5 days

Gross hemolysis

Monday through Sunday; Continuously

Same day

0 - 4 days: 130 - 275 mg/dL
4 days - 3 months: 130 - 360 mg/dL
3 months - 16 years: 203 - 360 mg/dL
16 years - 150 years: 200 - 390 mg/dL

Transferrin is a glycoprotein with a molecular weight of 79570 daltons. It consists of a polypeptide strand with two N-glycosidically linked oligosaccharide chains and exists in numerous isoforms. The rate of synthesis in the liver can be altered in accordance with the body’s iron requirements and iron reserves. Transferrin is the iron transport protein in serum. In cases of iron deficiency, the degree of transferrin saturation appears to be an extremely sensitive indicator of functional iron depletion. The ferritin levels are depressed when there is a deficiency of storage iron. In sideropenia, an iron deficiency can be excluded if the serum transferrin concentration is low, as in inflammations or – less commonly – in cases of ascorbic acid deficiency. In screening for hereditary hemochromatosis, transferrin saturation provides a better indication of the homozygous genotype than does ferritin. The treatment of anemia with erythropoietin in patients with renal failure is only effective when sufficient depot iron is present. The best monitoring procedure is to determine transferrin saturation during therapy. Transferrin saturation in connection with ferritin gives a conclusive prediction of the exclusion of iron overloading in patients with chronic liver disease. A variety of methods are available for determining transferrin including radial immunodiffusion, nephelometry and turbidimetry. The Roche transferrin assay is based on the immunological agglutination principle.